William Engelman

William Engelman, MD, serves as Medical Director at Edgewise Therapeutics since December 2024. Prior roles include Medical Director of Clinical Development at Fulcrum Therapeutics and Director of Patient Safety/Pharmacovigilance within the same organization. William has extensive experience in patient safety and risk management, having held positions such as Associate Director at Ionis Pharmaceuticals and Alnylam Pharmaceuticals. Other significant roles include Safety Analytics & Reporting Lead at Shire and Principal Safety Scientist at Sunovion Pharmaceuticals. William’s career began as a pediatric resident at the University of Massachusetts and includes research coordination at the Hospital of the University of Pennsylvania. William earned a Medical Doctorate from Temple University and a BS in Engineering from Michigan State University.